Jeuken JW - Search Results

1

Multiplex blood reporters for simultaneous monitoring of cellular processes.

Bovenberg MS, Degeling MH, Hejazi S, Amante RJ, van Keulen M, Jeuken JW, Akbaripanahi S, Vleggeert-Lankamp CL, Tannous M, Wesseling P, Wurdinger T, Tannous BA. Bovenberg MS, et al. Among authors: jeuken jw. Anal Chem. 2013 Nov 5;85(21):10205-10. doi: 10.1021/ac401798v. Epub 2013 Oct 16. Anal Chem. 2013. PMID: 24131224 Free PMC article.

2

Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis.

Hiddingh L, Raktoe RS, Jeuken J, Hulleman E, Noske DP, Kaspers GJ, Vandertop WP, Wesseling P, Wurdinger T. Hiddingh L, et al. Sci Rep. 2014 Jun 11;4:5260. doi: 10.1038/srep05260. Sci Rep. 2014. PMID: 24919120 Free PMC article.

3

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

Hiddingh L, Tannous BA, Teng J, Tops B, Jeuken J, Hulleman E, Boots-Sprenger SH, Vandertop WP, Noske DP, Kaspers GJ, Wesseling P, Wurdinger T. Hiddingh L, et al. Oncotarget. 2014 Jan 30;5(2):363-74. doi: 10.18632/oncotarget.1620. Oncotarget. 2014. PMID: 24495907 Free PMC article.

4

Molecular diagnostics as a tool to personalize treatment in adult glioma patients.

Jeuken JW, van der Maazen RW, Wesseling P. Jeuken JW, et al. Technol Cancer Res Treat. 2006 Jun;5(3):215-29. doi: 10.1177/153303460600500305. Technol Cancer Res Treat. 2006. PMID: 16700618 Free article. Review.

5

MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.

Jeuken JW, Wesseling P. Jeuken JW, et al. J Pathol. 2010 Dec;222(4):324-8. doi: 10.1002/path.2780. J Pathol. 2010. PMID: 20976706

6

Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization.

Claes A, Wesseling P, Jeuken J, Maass C, Heerschap A, Leenders WP. Claes A, et al. Mol Cancer Ther. 2008 Jan;7(1):71-8. doi: 10.1158/1535-7163.MCT-07-0552. Epub 2008 Jan 9. Mol Cancer Ther. 2008. PMID: 18187807

7

Comparative genomic hybridization: practical guidelines.

Jeuken JW, Sprenger SH, Wesseling P. Jeuken JW, et al. Diagn Mol Pathol. 2002 Dec;11(4):193-203. doi: 10.1097/00019606-200212000-00002. Diagn Mol Pathol. 2002. PMID: 12459635

8

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.

Jeuken J, Cornelissen S, Boots-Sprenger S, Gijsen S, Wesseling P. Jeuken J, et al. J Mol Diagn. 2006 Sep;8(4):433-43. doi: 10.2353/jmoldx.2006.060012. J Mol Diagn. 2006. PMID: 16931583 Free PMC article.

9

Re: multiplex ligation dependent probe amplification for the detection of 1p and 19q loss in oligodendroglial tumors.

Jeuken JW, Boots-Sprenger SH, Wesseling P. Jeuken JW, et al. Brain Pathol. 2005 Oct;15(4):364; author reply 365. doi: 10.1111/j.1750-3639.2005.tb00120.x. Brain Pathol. 2005. PMID: 16389947 Free PMC article. No abstract available.

10

Molecular pathogenesis of oligodendroglial tumors.

Jeuken JW, von Deimling A, Wesseling P. Jeuken JW, et al. J Neurooncol. 2004 Nov;70(2):161-81. doi: 10.1007/s11060-004-2748-1. J Neurooncol. 2004. PMID: 15674476 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters